Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab179378-100μg
|
100μg |
10
|
$59.90
|
|
|
Ab179378-1mg
|
1mg |
4
|
$289.90
|
|
|
Ab179378-5mg
|
5mg |
1
|
$749.90
|
|
|
Ab179378-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,189.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Divozilimab (anti-CD20) - Primary antibody, specific to MS4A1, >95%, high purity, Human IgG1 |
|---|---|
| Synonyms | APY antibody | ATOPY antibody | B lymphocyte antigen CD20 antibody | B Lymphocyte Cell Surface Antigen B1 antibody | B-lymphocyte antigen CD20 antibody | B-lymphocyte cell-surface antigen B1 antibody | B-lymphocyte surface antigen B1 antibody | B1 antibod |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | MS4A1 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Divozilimab (anti-CD20) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab (anti-CD20) can be used for multiple sclerosis research. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 26.8 kDa (Light Chain) & 51.7 kDa (Heavy Chain), under reducing conditions; 181.2 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 2254061-60-2 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Divozilimab (anti-CD20) (Ab179378) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD20 with Divozilimab (anti-CD20) (Ab179378) conjugated with biotin (right panel) compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156150).
Divozilimab (anti-CD20) (Ab179378) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD20 (red) with Divozilimab (anti-CD20) (Ab179378) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.
Divozilimab (anti-CD20) (Ab179378) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD20 (red) with Divozilimab (anti-CD20) (Ab179378). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Divozilimab (anti-CD20) (Ab179378) - Flow Cytometry
Flow Cytometry analysis of Ramos cells labelling CD20 (red) with Divozilimab (anti-CD20) (Ab179378). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Divozilimab (anti-CD20) (Ab179378) - SEC
The purity of Divozilimab (anti-CD20) (Ab179378) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Apr 02, 2024 | Ab179378 | |
| Certificate of Analysis | Apr 02, 2024 | Ab179378 | |
| Certificate of Analysis | Apr 02, 2024 | Ab179378 |
Starting at $29.90
Starting at $109.90
Starting at $39.90
Starting at $109.90
Starting at $39.90
Starting at $25.90
Starting at $49.90
Starting at $39.90
Starting at $199.90
Starting at $39.90
Starting at $19.90
Starting at $109.90
Starting at $49.90
Starting at $46.90
Starting at $109.90